Fast killing kinetics, significant therapeutic index, and high stability of melittin-derived antimicrobial peptide.

Akbari, Reza et al.·Amino acids·2022·
RPEP-059692022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

MDP1 and MDP2 are 252- and 132-fold more therapeutically effective than melittin.

Key Numbers

How They Did This

The study evaluated the killing kinetics, toxicity, and stability of MDP1 and MDP2, along with structural analysis.

Why This Research Matters

With the rise of drug-resistant bacteria, new antimicrobial agents like MDP1 and MDP2 are crucial for effective treatment. Their low toxicity and high stability make them promising candidates for further development.

What This Study Doesn't Tell Us

The study primarily focuses on in vitro results, and further research is needed to confirm efficacy in vivo.

Trust & Context

Original Title:
Fast killing kinetics, significant therapeutic index, and high stability of melittin-derived antimicrobial peptide.
Published In:
Amino acids, 54(9), 1275-1285 (2022)
Database ID:
RPEP-05969

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-05969·https://rethinkpeptides.com/research/RPEP-05969

APA

Akbari, Reza; Hakemi Vala, Mojdeh; Sabatier, Jean-Marc; Pooshang Bagheri, Kamran. (2022). Fast killing kinetics, significant therapeutic index, and high stability of melittin-derived antimicrobial peptide.. Amino acids, 54(9), 1275-1285. https://doi.org/10.1007/s00726-022-03180-2

MLA

Akbari, Reza, et al. "Fast killing kinetics, significant therapeutic index, and high stability of melittin-derived antimicrobial peptide.." Amino acids, 2022. https://doi.org/10.1007/s00726-022-03180-2

RethinkPeptides

RethinkPeptides Research Database. "Fast killing kinetics, significant therapeutic index, and hi..." RPEP-05969. Retrieved from https://rethinkpeptides.com/research/akbari-2022-fast-killing-kinetics-significant

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.